Media coverage in the form of two videos on YouTube dealing with Japanese efforts in the war against malaria in Burkina Faso have been produced under the SEmalvac project, which is supported by the Japanese Global Health Innovative Technology Fund (GHIT). The European Vaccine Initiatite, the Centre national de recherche et de formation sur le paludisme (CNRFP) and Osaka University are grateful to GHIT for its financial support.
Two years after the completion of the European Commission funded, EVI co-ordinated TRANSVAC project, results are still emerging, such as the recent article in PLOS neglected tropical diseases: Deep Sequencing Analysis of the Ixodes ricinus Haemocytome
Commissioned research for European Small and Medium size Enterprises (SME) and Public Health Organizations.
The ADITEC project is looking to support SMEs and public health organizations from within or outside the ADITEC consortium in vaccine development work that will result in public health benefit. We are actively seeking research proposals clearly aimed at vaccine development, where specific support can be requested in the areas listed below. These services are offered by current ADITEC consortium partners and are available free of charge to the requesting SME or public health organization, upon approval of the proposal.
Deadline: 30 October 2015 5:00 p.m. CET
Muhammed Afolabi (MRC Gambia) received an ASTMH 2015 Annual Meeting Travel Award that is supported in part by the Bill & Melinda Gates Foundation.
The WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance is delighted to announce to you its maiden Vaccine Pharmacovigilance Fellowship Programme. Deadline for registration is 21st August 2015. For enquiries kindly contact us at training [at] who-pvafrica [dot] org
EVI congratulates GlaxoSmithKline and PATH Malaria Vaccine Initiative (MVI) on their resounding success on the development of MosquirixTM, also known as RTS,S, for use in children aged six weeks to 17 months.
Dr. Michael Makanga will replace Professor Charles Mgone as Eecutive Director of The European & Developing Countries' Clinical Trials Partnership (EDCTP) in January 2016.
Dr. Makanga comes from a position as Head of EDCTP Africa Office in Cape Town, which he has held since 2008.
- 1 of 20